Una candidatura completa en un minuto
Currículum y carta de presentación personalizados, listos para enviar.
The Division of Medical Image Computing (MIC) at the German Cancer Research Center (DKFZ) in Heidelberg invites applications for PhD positions in agentic AI for medical image analysis, starting January 2027. Candidates will develop AI agents that interpret medical images, integrate clinical information, and learn from feedback, with access to clinical partners and extensive computing resources.
The program offers fully funded PhD submission, collaboration with international partners, and
The German Cancer Research Center (DKFZ) is one of Europe’s largest cancer research centers. “Research for a life without cancer" is the mission of our world‑class scientists and all our team members.
We investigate how cancer develops, identify cancer risk factors and search for new cancer prevention strategies. We develop new methods with which tumors can be diagnosed more precisely and cancer patients can be treated more successfully. Every contribution counts – whether in research, administration or infrastructure. This is what makes our daily work so meaningful and exciting.
TheDivision of Medical Image Computing (MIC) at the German Cancer Research Center (DKFZ) in Heidelberg, starting in January 2027, is offering
PhD Positions in Agentic AI for Medical Image Analysis
Reference number: 2026-0230
Heidelberg Full-time Medical Image Computing
The Division of Medical Image Computing (MIC) is recruiting PhD candidates to develop AI agents that interpret medical images, use analysis tools, evaluate intermediate results, and adapt their approach based on evidence and feedback. Candidates will join a collaborative research environment with clinical partners, extensive computing infrastructure, and connections to initiatives such as Helmholtz Imaging.
We investigate how AI agents can combine medical images with clinical information, plan and execute analytical steps, learn from feedback, assess intermediate results, and respond appropriately to uncertainty or failure. Approaches may include reinforcement learning, multimodal learning, vision‑language models, planning, tool‑augmented language models, probabilistic modelling, and classical medical image analysis.
The individual PhD topic will be developed jointly based on the candidate’s interests, expertise, and the methodological questions arising across these applications.
You should have:
Previous experience with medical data is helpful but not required. We also welcome candidates with strong machine‑learning fundamentals who want to develop expertise in agentic AI.
We Offer Excellent framework conditions: state‑of‑the‑art equipment and opportunities for international networking at the highest level Access to international research networks Doctoral salary with the usual social benefits 30 days of vacation per year Flexible working hours Possibility of part‑time work Family‑friendly working environment Sustainable travel to work: subsidized Germany job ticket Unleash your full potential: targeted training and mentoring through the DKFZ International PhD Program and DKFZ Career Service Our Corporate Health Management Program offers a holistic approach to your well‑being
Constantin Ulrich Harsy Telefon: +49 6221 42-3552
The positions are initially limited to 3 years.
December 2, 2026
Applications by e‑mail cannot be accepted. Please also note that we cannot return applications submitted by post.
Are you interested?
Then become part of the DKFZ and join us in contributing to a life without cancer!
We are convinced that an innovative research and working environment thrives on the diversity of its employees. Therefore, we welcome applications from talented people, regardless of gender, cultural background, nationality, ethnicity, sexual identity, physical ability, religion and age. People with severe disabilities are given preference if they have the same aptitude.
We are subject to the regulations of the Infection Protection Act (IfSG). Therefore, all our employees must provide proof of immunity against measles.